









Markets
/
Stocks
/
nasdaq-bbnx
/

Beta Bionics Inc

BBNX

11.310USD

+0.070+0.62%

Close 03/25, 16:00（ET）Quotes delayed by 15 min

484.74MMarket Cap

LossP/E TTM



Beta Bionics Inc

11.310

+0.070+0.62%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Beta Bionics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2023Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

39.58%-8.63M

---8.73M

---13.59M

---19.98M

-124.97%-14.28M

---6.35M

Net income from continuing operations

25.64%-13.47M

---14.21M

---16.87M

---28.66M

3.93%-18.11M

---18.85M

Operating gains losses

1.70%538.00K

--385.00K

--347.00K

--604.00K

-2.76%529.00K

--544.00K

Other non-cash items

224.88%1.30M

--300.00K

---372.00K

---705.00K

-41.98%-1.04M

---736.00K

Change in working capital

58.74%-1.34M

--317.00K

---1.50M

---6.47M

-472.97%-3.24M

---566.00K

-Change in receivables

-22.75%-5.59M

---168.00K

---2.33M

--2.94M

-84.01%-4.56M

---2.48M

-Change in inventory

-39.70%-2.20M

---3.33M

---1.73M

---2.62M

-72.16%-1.58M

---916.00K

-Change in prepaid expenses

63.39%-413.00K

---1.79M

---1.99M

---1.62M

-308.70%-1.13M

---276.00K

-Change in other current assets

200.00%3.00K

---39.00K

--2.00K

--4.00K

103.45%1.00K

---29.00K

-Change in other current liabilities

10.86%868.00K

--711.00K

--1.54M

--480.00K

228.99%783.00K

--238.00K

Cash from non-recurring investing activities

Cash from operating activities

39.58%-8.63M

---8.73M

---13.59M

---19.98M

-124.97%-14.28M

---6.35M

Investing cash flow

Net cash from continuing investing activities

239.22%1.90M

--1.28M

--1.78M

--333.00K

79.23%561.00K

--313.00K

Capital expenditures

239.22%1.90M

--1.28M

--1.78M

--333.00K

79.23%561.00K

--313.00K

Net cash flow from disposal of fixed assets

239.22%1.90M

--1.28M

--1.78M

--333.00K

79.23%561.00K

--313.00K

Net cash flow from investment products

108.80%2.56M

--10.77M

--7.95M

---178.79M

58.00%-29.10M

---69.30M

Net cash flow from other investing activities

--45.30M

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

102.22%658.00K

--9.49M

--6.17M

---179.12M

57.39%-29.66M

---69.61M

Financing cash flow

Cash flow from continuous financing activities

-98.14%1.06M

--2.65M

--42.00K

--211.12M

632033.33%56.89M

--9.00K

Net cash flow from common stock issuance/repurchase

---904.00K

--0.00

--211.02M

----

Net cash flow from preferred stock issuance/repurchase

----

--59.66M

--0.00

Proceeds from stock option exercised by employees

5208.11%1.96M

--2.65M

--42.00K

--98.00K

311.11%37.00K

--9.00K

Proceeds from issuance of warrants

----

--1.00K

--0.00

Net cash flow from other financing activities

67.78%-904.00K

----

---2.81M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-98.14%1.06M

--2.65M

--42.00K

--211.12M

632033.33%56.89M

--9.00K

Net cash flow

Beginning cash balance

119.47%38.59M

--35.17M

--42.55M

--30.53M

-82.87%17.58M

--102.61M

Current period cash flow changes

-153.35%-6.91M

--3.41M

---7.38M

--12.02M

117.05%12.95M

---75.95M

Ending cash balance

3.75%31.68M

--38.59M

--35.17M

--42.55M

14.50%30.53M

--26.67M

Free cash flow

29.04%-10.53M

---10.01M

---15.37M

---20.31M

-122.82%-14.84M

---6.66M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

